These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10549282)

  • 21. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis.
    Conery AR; Cao Y; Thompson EA; Townsend CM; Ko TC; Luo K
    Nat Cell Biol; 2004 Apr; 6(4):366-72. PubMed ID: 15104092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.
    Shen X; Hu PP; Liberati NT; Datto MB; Frederick JP; Wang XF
    Mol Biol Cell; 1998 Dec; 9(12):3309-19. PubMed ID: 9843571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.
    Frederick JP; Liberati NT; Waddell DS; Shi Y; Wang XF
    Mol Cell Biol; 2004 Mar; 24(6):2546-59. PubMed ID: 14993291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.
    Kim KO; Sampson ER; Maynard RD; O'Keefe RJ; Chen D; Drissi H; Rosier RN; Hilton MJ; Zuscik MJ
    J Cell Biochem; 2012 Jun; 113(6):2156-66. PubMed ID: 22461172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
    Band AM; Björklund M; Laiho M
    J Biol Chem; 2009 Dec; 284(51):35441-9. PubMed ID: 19875456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3.
    Remy I; Montmarquette A; Michnick SW
    Nat Cell Biol; 2004 Apr; 6(4):358-65. PubMed ID: 15048128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SKI knockdown inhibits human melanoma tumor growth in vivo.
    Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
    Baldwin A; Pirisi L; Creek KE
    J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity.
    Pessah M; Marais J; Prunier C; Ferrand N; Lallemand F; Mauviel A; Atfi A
    J Biol Chem; 2002 Aug; 277(32):29094-100. PubMed ID: 12034730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
    Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
    Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
    Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
    Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
    Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
    Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
    Vo BT; Cody B; Cao Y; Khan SA
    Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
    Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.